The purpose of this file is to centrally contract the supply of RIBAVIRINA (DOE), ANTIRRETROVIRALES IN COMBINATION: LAMIVUDINA (DOE) / ZIDOVUDINA (DOE), ZOLEDRÓNICO ACID (DOE), BIVALIRUDINA (DOE) and RILUZOL (DOE) for all Osakidetza service organizations and privately owned and non-profit health centers, located in the Autonomous Community of Euskadi, within the framework provided for in article 30 of Law 8/1997, of June 26, on Healthcare Management of Euskadi, to sign a linkage agreement with Osakidetza / Basque Health Service. With this contract file whose conditions are established in this document, it is intended to cover the use of the drugs included in the file to meet the clinical needs of Osakidetza patients and related centers that are summarized in the report's memory.

LOT ONE - RIBAVIRINA (DOE) ORAL

Active substance: RIBAVIRINA (DOE)

Amount of active substance: 200 mg

Pharmaceutical Form: tablet / capsule

Packaging conditions: unit dose preferably

Maximum unit price: 0.08 euros / tablet or capsule

(Taxes not included)

N or of planned units: 10,000 tablets or capsules

(First year of contract)

Maximum estimated budget: 800.00 euros

(First year of contract)

LOT TWO - ANTIRRETROVIRALES IN COMBINATION: LAMIVUDINA (DOE) + ZIDOVUDINA (DOE)

Active substance: LAMIVUDINA (DOE) AND ZIDOVUDINA (DOE)

Amount of active substance: 150 mg and 300 mg

Pharmaceutical Form: tablet

Packaging conditions: unit dose preferably

Maximum unit price: 0.37 euros / tablet

(Taxes not included)

N or of planned units: 5,000 tablets

(First year of contract)

Maximum estimated budget: 1,850.00 euros

(First year of contract)

LOT THREE - ZOLEDRONIC ACID (DOE) concentrate for solution for infusion 5 ml

Active ingredient: ZOLEDRONIC ACID (DOE)

Amount of active substance: 4 mg

Pharmaceutical Form: concentrate for solution for infusion 5 ml

Packaging conditions: unit dose

Maximum unit price: 2.51 euros / unit

(Taxes not included)

N or of planned units: 1,500 units

(First year of contract)

Maximum estimated budget: 3,765.00 euros

(First year of contract)

LOT FOUR - ZOLEDRONIC ACID (DOE) solution for infusion 100 ml

Active ingredient: ZOLEDRONIC ACID (DOE)

Amount of active substance: 4 mg

Pharmaceutical Form: 100ml infusion solution

Packaging conditions: unit dose

Maximum unit price: 4.34 euros / unit

(Taxes not included)

N or of planned units: 10,000 units

(First year of contract)

Maximum estimated budget: 43,400.00 euros

(First year of contract)

LOT FIVE - ZOLEDRONIC ACID (DOE) solution for infusion 100 ml

Active ingredient: ZOLEDRONIC ACID (DOE)

Amount of active substance: 5 mg

Pharmaceutical Form: 100ml infusion solution

Packaging conditions: unit dose

Maximum unit price: 12.00 euros / unit

(Taxes not included)

N or of planned units: 800 units

(First year of contract)

Maximum estimated budget: 9,600.00 euros

(First year of contract)

LOT SIX - BIVALIRUDINA (DOE)

Active substance: BIVALIRUDINA (DOE)

Amount of active substance: 250 mg

Pharmaceutical form: vial

Packaging conditions: unit dose preferably

Maximum unit price: 200 euros / 250 mg vial

(Taxes not included)

N or of planned units: 100 vials of 250 mg

(First year of contract)

Maximum estimated budget: 20,000.00 euros

(First year of contract)

LOT SEVEN - RILUZOL (DOE) ORAL SUSPENSION

Active substance: RILUZOL (DOE)

Amount of active substance: 5 mg / ml

Pharmaceutical form: oral suspension

Packaging conditions: unit dose

Maximum unit price: 76.06 euros / oral suspension

(Taxes not included)

N or of planned units: 1000 units

(First year of contract)

Maximum estimated budget: 76,060.00 euros

(First year of contract)